Testing Your Board's Stakeholder Assumptions Before a Major Strategic Decision

Start with what the board actually believes

Every major strategic paper contains a set of stakeholder assumptions, most of them unwritten. The regulator will accept the rationale. Institutional shareholders will back the capital ask. The rating agencies will hold. Distribution partners will stay. Staff in the affected division will absorb the change. These assumptions are load-bearing, but they are rarely surfaced with the same rigour as the financial model.

The first job is to write them down. Take the board paper and extract every claim that depends on a third party behaving in a particular way. You will typically find between eight and fifteen. If the list is shorter, you have not looked hard enough.

Separate the assumptions that matter

Not every assumption needs testing. Sort them on two axes: how much the decision depends on the assumption being correct, and how confident you actually are. Confidence should be based on recent, direct evidence, not on relationships, precedent, or what someone said at a conference.

The assumptions worth investing in are the ones where the decision breaks if you are wrong, and where your evidence is older than six months, second-hand, or based on a single source. This is usually a shortlist of three to five. Everything else can be monitored rather than tested.

Design the validation to be falsifiable

Most stakeholder validation fails because it is designed to confirm, not to test. A general counsel calls a familiar contact at the regulator and gets a warm reception. An IR team sounds out two supportive shareholders. The board hears reassurance and moves on.

Good validation looks different. For each critical assumption, define in advance what evidence would disprove it. If you believe the PRA will accept a particular capital treatment, what specific pushback would tell you they will not? If you believe your top ten shareholders will support a strategic pivot, what level of scepticism from which names would change the plan?

Then go looking for that disconfirming evidence deliberately. Speak to the stakeholders most likely to object, not the ones most likely to agree. Use intermediaries who can ask harder questions than you can ask directly. Ask about the second-order concerns, not the headline position.

Sequence the conversations correctly

Order matters. Test with stakeholders whose views can be gathered without signalling intent first: former regulators, sell-side analysts, ex-employees of key counterparties, trade body staff. This gives you a baseline before you approach anyone whose view you might inadvertently shape by asking.

Move to direct stakeholder soundings only when you have a clear hypothesis to test and a defined question. Vague listening exercises produce vague reassurance. Specific questions produce usable signal.

Keep the internal circle tight. If a market entry, disposal, or capital action leaks through the validation process itself, you have created a bigger problem than the one you were trying to solve.

What most boards get wrong

Three failures show up repeatedly.

First, treating the CEO's relationship map as validation. The chief executive's read on the regulator, the top shareholder, or the key partner is an input, not a test. It carries its own selection bias.

Second, confusing engagement with agreement. A stakeholder who has been briefed is not the same as a stakeholder who has committed. Ask what they would say if asked publicly, not whether they understand your position.

Third, running validation too late. By the time a paper is in final draft, the cost of surfacing a broken assumption is high enough that people stop looking. The right time to test is when the strategic direction is set but the execution path is still open.

Calibrate the confidence the board should demand

Before the decision paper goes up, the board should see, for each critical stakeholder assumption: the claim, the evidence base, the date of the most recent direct test, the identity of the person who owns it, and the disconfirming evidence that was sought and not found. If any of those five fields is thin, the assumption has not been validated. It has been asserted.

Your next step

Take the most recent strategic paper your board approved or is about to approve. Extract the stakeholder assumptions. Score each on dependency and confidence. If more than two critical assumptions rest on evidence you cannot date, source, or falsify, the decision is not ready.